Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Flanagan W. Michael | Dec 18, 2024 | Sell | 12,742 | $32.66 | $420,000 |
| MacLean Michael F | Dec 18, 2024 | Sell | 11,151 | $32.66 | $360,000 |
| Boyce Sarah | Dec 18, 2024 | Sell | 31,855 | $32.66 | $1M |
| McCarthy Teresa | Dec 18, 2024 | Sell | 11,151 | $32.66 | $360,000 |
| McCarthy Teresa | Dec 16, 2024 | Sell | 25,000 | $33.2642 | $830,000 |
| Flanagan W. Michael | Dec 11, 2024 | Sell | 24,000 | $35.7667 | $860,000 |
| LEVIN ARTHUR A | Nov 19, 2024 | Sell | 3,323 | $42.1224 | $140,000 |
| McCarthy Teresa | Nov 18, 2024 | Sell | 25,000 | $41.1408 | $1M |
| LEVIN ARTHUR A | Oct 21, 2024 | Sell | 5,000 | $46.6335 | $230,000 |
| McCarthy Teresa | Oct 16, 2024 | Sell | 25,000 | $48.5204 | $1.2M |
| Thompson Tamar | Oct 7, 2024 | Sell | 30,000 | $44.9753 | $1.3M |
| Flanagan W. Michael | Oct 1, 2024 | Sell | 62,500 | $47.6178 | $3M |
| McCarthy Teresa | Sep 23, 2024 | Sell | 13,153 | $44.0004 | $580,000 |
| Flanagan W. Michael | Sep 23, 2024 | Sell | 13,153 | $44.0004 | $580,000 |
| Flanagan W. Michael | Sep 23, 2024 | Sell | 11,847 | $43.8926 | $520,000 |
| Boyce Sarah | Sep 23, 2024 | Sell | 32,880 | $44.0001 | $1.4M |
| MacLean Michael F | Sep 23, 2024 | Sell | 11,510 | $44 | $510,000 |
| LEVIN ARTHUR A | Sep 19, 2024 | Sell | 5,000 | $45.7316 | $230,000 |
| Flanagan W. Michael | Sep 11, 2024 | Sell | 62,500 | $40.4002 | $2.5M |
| Flanagan W. Michael | Sep 11, 2024 | Sell | 34,000 | $40.3987 | $1.4M |
| Flanagan W. Michael | Sep 11, 2024 | Sell | 14,894 | $40.3972 | $600,000 |
| McCarthy Teresa | Sep 11, 2024 | Sell | 25,000 | $40.4017 | $1M |
| LEVIN ARTHUR A | Aug 19, 2024 | Sell | 5,000 | $45.1893 | $230,000 |
| Boyce Sarah | Aug 6, 2024 | Sell | 28,000 | $43.3508 | $1.2M |
| LEVIN ARTHUR A | Jul 19, 2024 | Sell | 5,000 | $45.0138 | $230,000 |
| Boyce Sarah | Jul 9, 2024 | Sell | 28,000 | $39.9315 | $1.1M |
| LEVIN ARTHUR A | Jun 20, 2024 | Sell | 5,000 | $37.5901 | $190,000 |
| MacLean Michael F | Jun 18, 2024 | Sell | 11,228 | $39.1294 | $440,000 |
| Boyce Sarah | Jun 18, 2024 | Sell | 32,074 | $39.1295 | $1.3M |
| Flanagan W. Michael | Jun 18, 2024 | Sell | 10,106 | $39.1297 | $400,000 |
| McCarthy Teresa | Jun 18, 2024 | Sell | 9,864 | $39.1294 | $390,000 |
| Boyce Sarah | Jun 14, 2024 | Sell | 35,767 | $40.0784 | $1.4M |
| Boyce Sarah | Jun 13, 2024 | Sell | 164,233 | $40.076 | $6.6M |
| LEVIN ARTHUR A | Jun 13, 2024 | Sell | 60,000 | $40.0797 | $2.4M |
| MacLean Michael F | Jun 12, 2024 | Sell | 104,245 | $35.7153 | $3.7M |
| Boyce Sarah | Jun 12, 2024 | Sell | 100,000 | $35.7302 | $3.6M |
| LEVIN ARTHUR A | Jun 12, 2024 | Sell | 40,000 | $35.0657 | $1.4M |
| Boyce Sarah | Jun 4, 2024 | Sell | 28,000 | $27.4207 | $770,000 |
| LEVIN ARTHUR A | May 20, 2024 | Sell | 5,000 | $29.8962 | $150,000 |
| MacLean Michael F | May 14, 2024 | Sell | 75,000 | $28.2806 | $2.1M |
| Boyce Sarah | May 7, 2024 | Sell | 28,000 | $25.5375 | $720,000 |
| LEVIN ARTHUR A | Apr 19, 2024 | Sell | 5,000 | $22.8246 | $110,000 |
| LEVIN ARTHUR A | Apr 3, 2024 | Sell | 20,000 | $27.1107 | $540,000 |
| Boyce Sarah | Apr 2, 2024 | Sell | 28,000 | $26.2471 | $730,000 |
| LEVIN ARTHUR A | Mar 19, 2024 | Sell | 5,000 | $23.9695 | $120,000 |
| MacLean Michael F | Mar 13, 2024 | Sell | 40,000 | $24.519 | $980,000 |
| LEVIN ARTHUR A | Mar 12, 2024 | Sell | 25,000 | $22.0366 | $550,000 |
| Boyce Sarah | Mar 12, 2024 | Sell | 28,000 | $22.6315 | $630,000 |
| LEVIN ARTHUR A | Mar 12, 2024 | Sell | 2,641 | $22 | $58,000 |
| Boyce Sarah | Mar 8, 2024 | Sell | 84,000 | $21.3894 | $1.8M |
| Boyce Sarah | Mar 1, 2024 | Sell | 84,000 | $20.1346 | $1.7M |
| LEVIN ARTHUR A | Jan 22, 2024 | Sell | 1,859 | $10.13 | $19,000 |
| Boyce Sarah | Jan 22, 2024 | Sell | 5,092 | $10.13 | $52,000 |
| Flanagan W. Michael | Jan 22, 2024 | Sell | 4,129 | $10.13 | $42,000 |
| McCarthy Teresa | Jan 22, 2024 | Sell | 2,065 | $10.13 | $21,000 |
| MacLean Michael F | Jan 22, 2024 | Sell | 1,616 | $10.13 | $16,000 |
| LEVIN ARTHUR A | Mar 15, 2023 | Sell | 100 | $22.01 | $2,200 |
| LEVIN ARTHUR A | Feb 14, 2023 | Sell | 9,477 | $23.6246 | $220,000 |
| LEVIN ARTHUR A | Feb 14, 2023 | Sell | 523 | $24.2381 | $13,000 |
| Boyce Sarah | Feb 3, 2023 | Sell | 3,221 | $24.26 | $78,000 |
| Boyce Sarah | Feb 2, 2023 | Sell | 45,879 | $24.3628 | $1.1M |
| Boyce Sarah | Feb 1, 2023 | Sell | 900 | $24.2716 | $22,000 |
| LEVIN ARTHUR A | Jan 12, 2023 | Sell | 10,000 | $22.0028 | $220,000 |
| LEVIN ARTHUR A | Dec 29, 2022 | Sell | 40,000 | $22.0142 | $880,000 |
What's the latest insider transaction for Avidity Biosciences?
The most recent insider transaction for Avidity Biosciences was conducted by Flanagan W. Michael, who sold 12,742 shares on December 18, 2024 at a price of $32.66 per share.
Which insider has sold the most RNA stock over the last two years?
Boyce Sarah has sold the most RNA stock in the last 2 years, with a total value of $25M.
What is the total value of insider transactions for Avidity Biosciences (RNA) in the last 2 years?
The total value of insider transactions for Avidity Biosciences in the last 2 years is negative, amounting to -$58M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Avidity Biosciences' market confidence?
Over the last 2 years, insider transactions for Avidity Biosciences have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
